(Reuters) – Moderna Inc said on Wednesday it will not be ready to apply for emergency approval for its potential COVID-19 vaccine before the U.S. presidential elections in November, the Financial Times reported.
The company’s chief executive officer, Stphane Bancel, told FT that he did not expect to have full approval to distribute the drug to all sections of the U.S. population until next spring. (https://on.ft.com/36h2LXD)
Moderna did not immediately respond to Reuters request for comment.
(Reporting by Trisha Roy in Bengaluru; Editing by Amy Caren Daniel)
